Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.05x is 100% above its 4-year average of -814.57x, near the high end of its 4-year range (-5218.00x–0.43x).
1095.80% below its 12-month average of -0.09x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2025 (2025-06-30): -0.28x.
INTEREST COVERAGE RATIO
-1.05x
INTEREST COVERAGE RATIO AVG TTM
-0.09x
INTEREST COVERAGE RATIO AVG 3Y
-0.36x
INTEREST COVERAGE RATIO AVG 5Y
-814.57x
INTEREST COVERAGE RATIO AVG 10Y
-88.48x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1095.80%
CURRENT VS 3Y AVG
-194.06%
CURRENT VS 5Y AVG
+99.87%
CURRENT VS 10Y AVG
+98.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
+81.87%
vs the sector median at left
Nuwellis, Inc.
Market Cap
$2.67M
Interest Coverage Ratio
-1.05x
TTM Avg
-0.09x
3Y Avg
-0.36x
5Y Avg
-814.57x
Market Cap
$2.56M
Interest Coverage Ratio
673.25x
TTM Avg
673.25x
3Y Avg
673.25x
5Y Avg
673.25x
Market Cap
$2.55M
Interest Coverage Ratio
-238.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69M
Interest Coverage Ratio
-4606.42x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.54M
Interest Coverage Ratio
-81.61x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.37M
Interest Coverage Ratio
-168.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nuwellis, Inc. (NUWE) | $2.67M | -1.05x | -0.09x | -0.36x | -814.57x |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | 673.25x | 673.25x | 673.25x | 673.25x |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.55M | -238.27x | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.69M | -4606.42x | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | -81.61x | N/A | N/A | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.45M | N/A | N/A | N/A | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.37M | -168.25x | N/A | N/A | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.36M | -8.45x | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.27M | N/A | N/A | N/A | N/A |
Interest Coverage
-1.1x
Debt/Equity
N/A
Current Ratio
1.97
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-06-30 | -0.28x |
| 2024-12-31 | 0.43x |
| 2024-06-30 | -0.41x |
| 2023-12-31 | -1.03x |
| 2022-12-31 | -0.49x |
| 2022-03-31 | -80.29x |
| 2021-12-31 | -206.24x |
| 2021-09-30 | -276.37x |
| 2021-06-30 | -2363.00x |
| 2021-03-31 | -5218.00x |
| 2019-09-30 | -4507.00x |
| 2018-12-31 | -425.30x |
| 2017-12-31 | -174.20x |
| 2016-09-30 | -59.74x |
| 2016-06-30 | -19.24x |
| 2016-03-31 | -19.89x |
| 2015-09-30 | -22.24x |
| 2015-06-30 | -41.98x |
| 2015-03-31 | -105.94x |
| 2014-12-31 | -93.75x |
| 2011-12-31 | -267.00x |
